Prevention of Cardiovascular and Other Systemic Adverse Outcomes in Patients with Asthma Treated with BiologicsMohsen Sadatsafavi, Κonstantinos Κostikas, Flavia Hoyte et al.|American Journal of Respiratory and Critical Care Medicine|2025Cited by 17
Response to Biologics Along a Gradient of T2 Involvement in Patients With Severe Asthma: A Data-Driven Biomarker Clustering ApproachEileen Wang, Bassam Mahboub, William Henley et al.|The Journal of Allergy and Clinical Immunology In Practice|2025Cited by 1
Impact of Biologic Initiation on New-onset of Corticosteroid-related Adverse Effects in Patients With Severe AsthmaDavid Price, T.N. Tran, B. Emmanuel et al.|American Journal of Respiratory and Critical Care Medicine|2025Cited by 0
Reply to Liu et al., Zhou et al., and Dong et al.Mohsen Sadatsafavi, Charlotte Suppli Ulrik, Trung N. Tran et al.|American Journal of Respiratory and Critical Care Medicine|2025Cited by 0